Autologous Platelet Rich Plasma (A-PRP) and Hyaluronic Acid (HA)
Cellular Matrix is a revolutionary innovation in aesthetic medicine that combines two treatment concepts in one for natural results.
Autologous Platelet Rich Plasma (A-PRP) provides an autologous resevoir of growth factors:
- Increases the production of collagen
- Enhances skin elasticity, tone and thickness
- Stimulates stem cell differentiation and proliferation
- Triggers angiogenesis
- Creates a volumising effect
The key molecule involved in skin moisture is hyaluronic acid (HA) that has unique capacity in retaining water
- More than 25 years of clinical experience in aesthetic medicine
- Major component of the extracellular matrix with important role in cellular proliferation and migration
- Binds water and creates volume
- Stimulates migration and proliferation of dermal cells
Immediate formation, in one easy step, of a cell-friendly HA network in which platelets are dispersed, using a system which is specifically approved for preparation of the combination of A-PRP and HA.
4 ml of the CellularMatrix combination is prepared using 4 ml of autologous blood in a single step closed system.
CellularMatrix contains 2 ml of natural, non-crosslinked, fermented HA (1550 KDa) at a concentration of 15 mg / ml (30mg total), in addition to the thixotropic cell-separation gel and the sodium citrate anticoagulant solution.
CellularMatrix contains non-crosslinked HA from fermentation and autologous PRP, both of which have excellent safety profiles in clinical practice.
HA increases the residence time of growth factors in tissue and creates a prolonged effect on stem cell migration and tissue regeneration beyond that of the A-PRP alone. Cellular Matrix Facelift restores the volume of tissue giving a youthful effect.
Regen Lab specializes in autologous platelet rich plasma (PRP™), standardized with Regenkit Medical Devices, in addition to the combination of platelets with cells, such as adipose tissue and MSC’s from bone marrow. PRP therapy and PRP injections, alone and in combination with other cells, are the most widely used cell therapies of regenerative medicine.